Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366991384> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4366991384 endingPage "670" @default.
- W4366991384 startingPage "664" @default.
- W4366991384 abstract "Evusheld is a combination injection of tixagevimab and cilgavimab and is indicated for the pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older. Its use has been advocated for immunosuppressed individuals, such as blood cancer patients, although uptake varies significantly between countries. Despite extensive use internationally, there has been limited analysis of potential psychological benefits that vulnerable patients might gain from receiving this prophylactic medication. In this study we have quantified four key psychological health parameters in blood cancer patients who received Evusheld (EQ5D-3L quality of life score, DSM5 Agoraphobia score, Duke’s Social Support Index and the hospital anxiety and depression score) and compared their responses with a control group of patients who did not receive Evusheld. We show that patients who opted for treatment had higher baseline markers of psychological stress and ill-health compared with non-treated individuals but that treatment with Evusheld significantly improved the psychological health of recipients and increased the level of physical social/work interactions over that of control patients. Although there are limitations with this small study, the findings strongly suggest that Evusheld prophylaxis can provide significant psychological benefits for vulnerable blood cancer patients who have significant anxiety about COVID-19 infection." @default.
- W4366991384 created "2023-04-27" @default.
- W4366991384 creator A5005630871 @default.
- W4366991384 creator A5009440313 @default.
- W4366991384 creator A5012590429 @default.
- W4366991384 creator A5019753679 @default.
- W4366991384 creator A5038336273 @default.
- W4366991384 creator A5053471988 @default.
- W4366991384 creator A5077695939 @default.
- W4366991384 creator A5078816263 @default.
- W4366991384 date "2023-04-24" @default.
- W4366991384 modified "2023-09-26" @default.
- W4366991384 title "Evusheld Prophylaxis Improves Social Interactions, Anxiety, Depression, Agoraphobia, and Quality of Life in Blood Cancer Patients" @default.
- W4366991384 cites W2039408383 @default.
- W4366991384 cites W2166281097 @default.
- W4366991384 cites W2473786944 @default.
- W4366991384 cites W3123804845 @default.
- W4366991384 cites W4200414040 @default.
- W4366991384 cites W4206657852 @default.
- W4366991384 cites W4213125812 @default.
- W4366991384 cites W4221019888 @default.
- W4366991384 cites W4247665917 @default.
- W4366991384 cites W4311376659 @default.
- W4366991384 doi "https://doi.org/10.3390/covid3050048" @default.
- W4366991384 hasPublicationYear "2023" @default.
- W4366991384 type Work @default.
- W4366991384 citedByCount "0" @default.
- W4366991384 crossrefType "journal-article" @default.
- W4366991384 hasAuthorship W4366991384A5005630871 @default.
- W4366991384 hasAuthorship W4366991384A5009440313 @default.
- W4366991384 hasAuthorship W4366991384A5012590429 @default.
- W4366991384 hasAuthorship W4366991384A5019753679 @default.
- W4366991384 hasAuthorship W4366991384A5038336273 @default.
- W4366991384 hasAuthorship W4366991384A5053471988 @default.
- W4366991384 hasAuthorship W4366991384A5077695939 @default.
- W4366991384 hasAuthorship W4366991384A5078816263 @default.
- W4366991384 hasBestOaLocation W43669913841 @default.
- W4366991384 hasConcept C118552586 @default.
- W4366991384 hasConcept C121608353 @default.
- W4366991384 hasConcept C126322002 @default.
- W4366991384 hasConcept C139719470 @default.
- W4366991384 hasConcept C159110408 @default.
- W4366991384 hasConcept C162324750 @default.
- W4366991384 hasConcept C2776317618 @default.
- W4366991384 hasConcept C2776867660 @default.
- W4366991384 hasConcept C2778678127 @default.
- W4366991384 hasConcept C2779951463 @default.
- W4366991384 hasConcept C558461103 @default.
- W4366991384 hasConcept C71924100 @default.
- W4366991384 hasConceptScore W4366991384C118552586 @default.
- W4366991384 hasConceptScore W4366991384C121608353 @default.
- W4366991384 hasConceptScore W4366991384C126322002 @default.
- W4366991384 hasConceptScore W4366991384C139719470 @default.
- W4366991384 hasConceptScore W4366991384C159110408 @default.
- W4366991384 hasConceptScore W4366991384C162324750 @default.
- W4366991384 hasConceptScore W4366991384C2776317618 @default.
- W4366991384 hasConceptScore W4366991384C2776867660 @default.
- W4366991384 hasConceptScore W4366991384C2778678127 @default.
- W4366991384 hasConceptScore W4366991384C2779951463 @default.
- W4366991384 hasConceptScore W4366991384C558461103 @default.
- W4366991384 hasConceptScore W4366991384C71924100 @default.
- W4366991384 hasIssue "5" @default.
- W4366991384 hasLocation W43669913841 @default.
- W4366991384 hasLocation W43669913842 @default.
- W4366991384 hasOpenAccess W4366991384 @default.
- W4366991384 hasPrimaryLocation W43669913841 @default.
- W4366991384 hasRelatedWork W100094312 @default.
- W4366991384 hasRelatedWork W2088478022 @default.
- W4366991384 hasRelatedWork W2158415380 @default.
- W4366991384 hasRelatedWork W2298731911 @default.
- W4366991384 hasRelatedWork W2377986053 @default.
- W4366991384 hasRelatedWork W2378173657 @default.
- W4366991384 hasRelatedWork W2468119980 @default.
- W4366991384 hasRelatedWork W2473086207 @default.
- W4366991384 hasRelatedWork W3009017328 @default.
- W4366991384 hasRelatedWork W3215444405 @default.
- W4366991384 hasVolume "3" @default.
- W4366991384 isParatext "false" @default.
- W4366991384 isRetracted "false" @default.
- W4366991384 workType "article" @default.